Epstein Secrets

05/05/us/bidens-new-flexible-vaccination-strategy-could- help-underserved-communities-experts-say.html> (5/5, Fazio, Depasquale, LaFraniere, Weiland, Walker, 20.6M) reports that public health experts "are praising President Biden's announcement that his Administration would create a federal stockpile of

e House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modena, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios <https://www.axios.com/us-biden- vaccine-patents-waiver-65478c91-5107-41ff-

ball.'" Public Heath Experts Praise Administration Over Vaccine Stockpile Program. The New York Times (5/5, Fazio, Depasquale, LaFraniere, Weiland, Walker, 20.6M) reports that public health experts "are praising President Biden's announcement that his Administration would create a federal stockpile of

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, induding Moderna, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufact

ders typically have the power to take military action on their own to save lives or prevent significant property damage in an urgent situation," but Walker "said the Pentagon EFTA00148087 essentially took that power and other authorities away from him ahead of a pro-Trump protest on Jan. 6.," which "

Biden said Tuesday that "he hopes to have enough vaccine for 300 million Americans by the end of the summer, ordering another 100 million doses from Pfizer and 100 million doses additional from Moderna. It comes as the global pandemic now reaches a staggering new toll: more than 100 million cases world

efore being approved," Center for Science in the Public Interest President Peter Lurie "said that was not unusual." The Wall Street Journal (10/22, Walker, Subscription Publication, 7.57M) reports that prior to the pandemic, Gilead sought to test the drug's efficacy in treating other strains of corona

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

ball." Public Heath Experts Praise Administration Over Vaccine Stockpile Program. The New York Times (5/5, Fazio, Depasquale, LaFraniere, Weiland, Walker, 20.6M) reports that public health experts "are praising President Biden's announcement that his Administration would create a federal stockpile of

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modema, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufac